$XBI $87.77
Pipeline Updates
$TGTX TG Therapeutics Announces Voluntary Withdrawal of the BLA/sNDA for U2 to Treat Patients with CLL and SLL.
$ANVS Annovis Bio Announces Publication of ANVS401 Mechanism of Action in Peer-Reviewed Pharmaceutics.
$BHVN BIOHAVEN REAL-WORLD STUDY HIGHLIGHTS INCREASED HEALTHCARE UTILIZATION AMONG AMERICANS WITH EPISODIC MIGRAINE HAVING HIGHER LEVELS OF MIGRAINE-RELATED DISABILITY.
Business Updates
$IMRA On April 12, 2022, the Board of Directors of IMARA Inc. approved a reduction of the Company’s workforce by approximately 83% across all areas of the Company, to a total of six remaining full-time employees.
Posted by DV/FS
Comments